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3Department of Psychology, Queens College, City University of New York, Flushing, New York 11367, 4Reynolds Oklahoma Center on Aging, Department of
Geriatric Medicine, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma 73104, 5Department of Pathology and Cell Biology, University
of South Florida School of Medicine, Tampa, Florida 33612, 6Department of Physiology and Pharmacology, Oregon Health & Science University, Portland,
Oregon 97239, 7Department of Neuroscience, University of Connecticut Medical School, Farmington, Connecticut 06030, and 8Department of Pediatrics,
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Intraventricular hemorrhage (IVH) results in neural cell death and white matter injury in premature infants. No therapeutic strategy is
currently available against this disorder. Bone morphogenetic protein (BMP) signaling suppresses oligodendrocyte development
through basic-helix-loop-helix (bHLH) transcription factors and promotes astrocytosis. Therefore, we hypothesized that IVH in prema-
ture newborns initiates degeneration and maturation arrest of oligodendrocyte lineage and that BMP inhibition alleviates hypomyelina-
tion, gliosis, and motor impairment in the survivors of IVH. To test the hypotheses, a rabbit model of IVH was used in which premature
rabbit pups (E29) are treated with intraperitoneal glycerol at 2 h of age to induce IVH; and the pups with IVH exhibit hypomyelination and
gliosis at 2 weeks of postnatal age. Maturation of oligodendrocyte lineage was evaluated by specific markers, and the expression of bHLH
transcription factors was assessed. BMP levels were measured in both premature rabbit pups and autopsy materials from premature
infants. Recombinant human noggin was used to suppress BMP action; and neurobehavioral performance, myelination and gliosis were
assessed in noggin-treated pups compared with untreated controls. We found that IVH resulted in apoptosis and reduced proliferation of
oligodendrocyte progenitors, as well as arrested maturation of preoligodendrocytes in rabbits. BMP4 levels were significantly elevated in
both rabbit pups and human premature infants with IVH compared with controls. Importantly, BMP inhibition by recombinant human
noggin restored the levels of phospho-Smad1/5/8, Olig2 transcription factor, oligodendrocyte maturation, myelination, astrocyte mor-
phology, and motor function in premature pups with IVH. Hence, BMP inhibition might enhance neurological recovery in premature
infants with IVH.
Introduction
Approximately 12,000 premature infants develop intraventricu-
lar hemorrhage (IVH) every year in the USA alone (Heuchan et
al., 2002). The hemorrhage typically originates in the germinal
matrix and often progresses to IVH with the rupture of the ven-
tricular ependyma. The germinal matrix, located on the head of
caudate nucleus beneath the ventricular ependyma, is a vascular-
ized collection of neuronal-glial precursor cells and is selectively
vulnerable to hemorrhage. IVH is associated with white matter
injury, manifesting as cerebral palsy and cognitive deficits in the
survivors (Armstrong et al., 1987; Bassan et al., 2007). No thera-
peutic or preventive strategy is currently available for the white
matter injury in premature infants with IVH. Hence, we asked
what the mechanism of white matter injury in IVH was and how
this could be prevented.
During human pregnancy, 23–35 weeks of gestation is the
window when oligodendrocyte (OL) lineage progresses through
distinct phenotypic stages—OL progenitors, pre-OL, immature
and then mature OL (Back et al., 2001). OL progenitors are iden-
tified by reactivity to PDGFR or NG2 antibody, pre-OLs are
reactive to O4 monoclonal antibody; and the immature OLs ex-
press galactocerebroside (O1 antigen) and 2,3-cyclic nucleotide
3-phosphodiesterase (CNPase). The mature OLs synthesize the
major myelin proteins—myelin basic protein and proteolipid
protein (Pfeiffer et al., 1993). Pre-OLs are vulnerable to oxidative
stress and to hypoxic-ischemic insults, whereas immature OLs
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are relatively resistant to these events (Back et al., 2005). Acute
hypoxia-ischemia in neonatal rats results in degeneration and
maturation arrest of pre-OLs, rendering hypomyelination in the
hypoxic-ischemic white matter (Segovia et al., 2008). However,
the distinctive changes in the transcriptional network that might
cause developmental arrest of OLs in neonatal models of brain
injury remains unknown.
The maturation of OLs is regulated by basic helix-loop-helix
(bHLH) transcription factors, including Olig1, Olig2, Id2, Id4,
and Sox10 (Nicolay et al., 2007). Loss- and gain-of-function ex-
periments have shown that these factors regulate OL differentia-
tion (Lu et al., 2002; Xin et al., 2005). BMP signaling pathways are
important regulators of the bHLH transcriptional factors and
oligodendrogenesis (Hall and Miller, 2004; See et al., 2007). Al-
though BMP is necessary for OL lineage maturation, BMP over-
expression inhibits OL lineage progression by suppressing Olig1
and Olig2 transcription factors (Nicolay et al., 2007). BMP pro-
motes astrocytosis and inhibits OL lineage commitment by di-
verting oligodendroglial precursors into astrocytic progenitors
(Gomes et al., 2003). On this basis, we hypothesized that IVH in
premature newborns would result in OL degeneration and dis-
tinctive disturbances in the levels of bHLH transcriptional fac-
tors, thereby arresting maturation of pre-OLs. We also postulated
that BMP might be elevated in IVH, and that BMP inhibition
would restore the transcription factors, maturation of OLs, my-
elination, astrocyte morphology, and neurological function in
the survivors of IVH. To test these hypotheses, we used our ani-
mal model, in which rabbit pups with glycerol-induced IVH ex-
hibit hypomyelination and gliosis at 2 weeks of postnatal age
(Chua et al., 2009).
Here we show that IVH resulted in apoptosis, reduced prolif-
eration, and arrested maturation of pre-OLs. BMP4 levels were
elevated in newborns with IVH than controls; and BMP inhibi-
tion restored myelination and neurological recovery in pups
with IVH.
Materials and Methods
Animal experiments. The Institutional Animal Care and Use Committee
of New York Medical College approved the use of animals for this study.
We obtained timed-pregnant New Zealand rabbits from Charles River
Laboratories. C-section was performed to deliver the pups prematurely
at E29 (full-term  32 d). We kept them in an infant incubator pre-
warmed to a temperature of 35°C. The pups were gavage-fed 1 ml of
rabbit milk at 4 h of age and then 2 ml every 12 h (100 ml/kg/d) for the
first 2 d. Subsequently, they were fed puppy formula (Esbilac), and feeds
were advanced to 125, 150, 200, 250, and 280 ml/kg at postnatal days 3, 5,
7, 10, and 14, respectively. The rabbit pups of either sex were adminis-
tered 50% glycerol (6.5 g/kg) intraperitoneally at 2 h of age to induce
IVH. Head ultrasound was performed at 6 h of age to evaluate the pres-
ence and severity of IVH using an Acuson Sequoia C256 (Siemens)
ultrasound machine. We classified IVH as (1) mild, not gross but micro-
scopic hemorrhage detected in H&E-stained brain sections; (2) moder-
ate, gross hemorrhage into lateral ventricles (two separate lateral
ventricles visualized); or (3) severe, gross IVH leading to fusion of lateral
ventricles into a common chamber (Fig. 1 A) (Vinukonda et al., 2010). As
microscopic IVH cannot be diagnosed by head ultrasound, an absence of
IVH in glycerol-treated pups indicated that the kit had either micro-
scopic or no IVH.
Noggin treatment. To inhibit BMP action, we treated rabbit pups with
human recombinant noggin (Invitrogen), starting at 24 h of age. The
severity of IVH was similar between the comparison groups—vehicle-
treated pups with IVH and noggin-treated pups with IVH. Briefly, pups
were restrained after being anesthetized with ketamine (35 mg/kg, i.m.)
and xylazine (5 mg/kg, i.m.). Intracerebroventricular (ICV) cannula
(catalog #0004760, Alzet, Durect ) was implanted in cerebral ventricle
using the following coordinates from bregma: 1 mm anterior, 4 mm
lateral, and 3 mm deep. The cannula was connected to an Alzet mini-
osmotic pump (model 1003D 1 l/hx3d; model 2001 1 l/hx7d), and the
pump was implanted between shoulder blades. Those pups, who were
killed at the end of day 3, received noggin infusion for 3 d (800 ng of
noggin in 100 l of saline); and pups, who were killed at day 7 or 14,
received noggin infusion for 7 d (1600 ng of noggin in 200 l of saline).
Human subjects. The Institutional Review Board of New York Medical
College (Valhalla, NY) approved the use of human autopsy materials for
this study. The study materials included forebrain tissue samples taken
from premature infants with and without IVH of 23–26 weeks of
gestational age and 3–5 d of postnatal age. Samples were obtained
24 h postmortem. We excluded premature infants with meningitis,
hypoxic-ischemic encephalopathy, culture proven sepsis, major con-
genital anomalies, and chromosomal defects. We included six infants
in each group–IVH and no IVH. The wall of the cerebral hemisphere in
premature infants consists of ventricular zone (VZ), subventricular zone
(SVZ), intermediate zone, cortical plate, and marginal zone as described
by the Boulder Committee (Bystron et al., 2008). In this study, we de-
scribed intermediate-zone embryonic white matter synonymously with
white matter and cortex for the cortical plate. Brain samples were pro-
cessed as described previously (Vinukonda et al., 2010).
Rabbit tissue collection and processing. We processed the tissues as pre-
viously described (Ballabh et al., 2007). The brain slices were immersion-
fixed in 4% paraformaldehyde in PBS (0.01 M, pH 7.4) for 18 h and then
were cryoprotected by immersing into 20% sucrose in 0.01 M PBS buffer
for 24 h followed by 30% sucrose for the next 24 h. Tissues were frozen
into optimum cutting temperature compound (Sakura). Frozen coronal
blocks were cut on a cryostat into 12 m sections.
Human tissue collection and processing. We processed the tissues as
described previously (Ballabh et al., 2007). Approximately 2- to 3-mm-
thick coronal slices were taken at the level of thalamostriate groove from
the frontal lobe. The coronal blocks from the frontal lobe included the
cortex, white matter, and germinal matrix. The samples were fixed in 4%
paraformaldehyde in PBS overnight and were then cryoprotected by im-
mersing into a 20% sucrose solution in PBS. The tissues were frozen
after embedding them into optimum cutting temperature compound
(Sakura). Frozen coronal blocks were cut into 15 m sections. For West-
ern blot analyses, pieces of tissues were directly harvested from the cor-
tex, white matter, and germinal matrix and were frozen immediately on
dry ice.
Immunohistochemistry. Immunostaining was performed as described pre-
viously (Ballabh et al., 2007). The primary antibodies used in experiments
included goat polyclonal BMP2 (catalog #sc-6895, Santa Cruz Biotechnol-
ogy), goat polyclonal BMP4 (catalog #sc-6896, Santa Cruz Biotechnology),
rabbit monoclonal Ki67 (catalog #275R-14, Cell Marque), goat polyclonal
Olig2 (catalog #AF-2418, R&D Systems), rabbit polyclonal Olig1 (catalog
#sc-48787, Santa Cruz Biotechnology), mouse monoclonal GFAP (catalog
#G6171; Sigma-Aldrich), rat monoclonal myelin basic protein (catalog
#AB7439, Abcam), mouse monoclonal caspase-3 (clone 3CSP01, catalog
#MS1121-P; Thermo Scientific), goat polyclonal PDGFR (catalog #AF307
NA, R&D Systems), mouse monoclonal NG2 (catalog #5384, Millipore),
mouse monoclonal Adenomatous Polyposis Coli, CC1 clone (APC) anti-
body (catalog #OP80, EMD Chemicals). Fluorescent double labeling with
O4 and O1 antibody (courtesy of Dr. Rashmi Bansal, University of Connect-
icut, Farmington, CT) used biotinylated O4 antibody. The secondary anti-
bodies used were Cy3 conjugate donkey anti-mouse, Cy3 conjugate donkey
anti-goat and FITC conjugate donkey anti-rat (Jackson Immunoresearch).
Briefly, we hydrated the fixed sections in 0.01 M PBS and incubated with the
primary antibodies diluted in PBS at 4°C overnight. After washing in PBS,
the sections were incubated with secondary antibody diluted in 1% normal
goat serum in PBS at room temperature for 60 min. Finally, after washes in
PBS, sections were mounted with Slow Fade Light Antifade reagent (Invit-
rogen) and were visualized under a confocal microscope (Nikon Instru-
ments). Stereology was performed using a fluorescent microscope
(Axioskop 2 plus; Carl Zeiss) with motorized specimen stage for automated
sampling (Applied Scientific Instrumentation), CCD color video camera
(Microfire; Optronics), and stereology software (Stereologer; Stereology Re-
source Center).
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Fluorescent in situ detection of DNA fragmentation (TUNEL). We per-
formed Fluoro-Jade (Millipore) and TUNEL staining on fixed brain sec-
tions as described previously (Georgiadis et al., 2008). For TUNEL
staining, 15-m-thick tissue sections were air dried on slides, hydrated in
0.01 M PBS, and permeabilized for 5 min in 1:1 ethanol:acetic acid. An
ApopTag-fluorescein in situ DNA fragmentation detection kit (catalog
#S7110; Millipore) was used to visualize TUNEL-labeled nuclei.
Quantification of oligodendrocytes, proliferation, and apoptosis. We
counted (1) O4 () and O1 () OL in double-labeled brain sections, (2)
O4 () OL colabeled for TUNEL staining and all TUNEL () nuclei, (3)
cells labeled with both K67 and Olig2 antibodies and all Ki67 () cells in
double-stained brain sections. From each brain, five coronal sections (20
m thick) were taken as every third section at the level of midseptal
nucleus. Counting was performed in an unbiased fashion and random
basis. In the periventricular zone (germinal matrix, caudate nucleus,
deep corona radiata, and corpus callosum around the ventricle) neural
cell proliferation and in the white matter (corpus callosum, corona radi-
ate and internal capsule) apoptotic OL-, O4-, and O1-positive OL were
quantified under confocal microscope using a 60 lens (Nikon Instru-
ments) by a blinded investigator. We counted objects in 25 images (5
images  5 coronal sections) per brain region for each pup (n  5– 6
pups each group) for every parameter.
Stereological assessment of myelin and astrocytes in the white matter.
Unbiased stereology methods, with assistance from a computerized soft-
ware system (Stereologer; Stereology Resource Center), were used to
quantify a range of parameters. Briefly, coronal sections were cut on
cryostat at a setting of 30 m thickness with a section sampling interval of
three (90 m) to achieve at least six sections at the level of midseptal
nucleus. The sections were double labeled with MBP antibody and DAPI
(nuclear stain) and quantified as follows. The reference spaces (corona
radiata, corpus callosum) were first outlined on the section under 4
objective. The volume of the outlined area (reference space) was quanti-
fied using a point counting probe (frame, 25  25 m; guard zone, 2 m;
interframe interval, 300 m). The total volume fraction (load) of myelin
labeled by antibodies to MBP through a defined reference space was
quantified using the object area fraction probe under 60 oil lens. For
Figure 1. IVH induces apoptosis. A, Coronal brain section through frontal lobe of E29 rabbit pup showing normal slit-like ventricle (white arrows, left panel), moderate hemorrhage in the ventricle
(arrowheads, middle panel) and severe hemorrhage resulting in fusion of the two ventricles (arrowheads, right panel). Scale bar, 1 cm. B, Representative immunofluorescence of cryosections from
3-d-old E29 pups with and without IVH double labeled for TUNEL and O4 antigen. Above and to the right of the images are orthogonal views in x–z and y–z planes of a composite of z-stack of a series
of confocal images taken 0.6 m apart. TUNEL () nuclei embedded in O4-labeled OL indicate apoptotic OL (arrows). Note apoptotic OL in pups with IVH, but not in controls without IVH. O4 ()
OLs are shown (arrowheads). Insets show O4 immunolabeling (left) and apoptotic OLs (right) under high magnification. Scale bars, 25 m. C, The bar graph shows mean  SEM (n  5– 6 each).
Apoptotic OLs were more abundant in the corpus callosum (CC) and corona radiata (CR) of pups with IVH pups than glycerol-treated controls without IVH at both days 3 and 7, but not in the internal
capsule (IC). D, Representative immunofluorescence of cryosections from 3-d-old E29 pups with and without IVH double labeled for TUNEL- and APC-specific antibody. Note that TUNEL () nuclei
(arrow) do not overlap with APC () OLs (arrowhead). Scale bar, 25 m. E, Representative Western blot analyses for caspase-3 in the forebrain of premature rabbit pups with and without IVH at
postnatal days 3, 7 and 14. Each lane represents lysate from whole coronal slice taken at the level of midseptal nucleus of one brain. Values are normalized to -actin levels. Ctrl, Control. F, Bar chart
shows mean  SEM (n  6 each). Cleaved caspase-3 (active caspase-3, 12 kDa) levels were higher in pups with than pups without IVH at both day 3 and 7, unlike day 14. *p  0.05, **p  0.01,
and ***p  0.001 for the comparison between pups with and pups without IVH.
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the area fraction probe (frame, 25  25 m; guard zone, 2 m; inter-
frame interval, 400 m), the user clicked on the grid points that touched
myelin fibers in sections stained with MBP. The area fraction of myeli-
nation was quantified as the ratio of product of the area per point and
number of points hitting reference area [a(point)  Pref] over the prod-
uct of the area per point and number of points hitting the sampled area
[a(point)  Psamp], as reported recently (Mouton et al., 2009). Sampling
continued until the coefficient of error was 0.10. To assess gliosis, we
performed the following: (1) astrocyte count (labeled against GFAP)
using the optical dissector method (frame, 25  25 m; guard zone, 2
m; interframe interval, 280 m); and (2) total volume fraction of as-
trocyte cell body and glial fibers (Mouton et al., 2009). Volume fraction
of astrocytes was quantified in similar fashion as for myelin.
Western blot analyses. We homogenized the frozen brain tissue in sam-
ple buffer (3% SDS, 10% glycerol, 62.5 mmol of TRIS-HCl, and 100 mM
DTT) using a mechanical homogenizer and boiled the samples immedi-
ately for 5 min. We next determined protein concentration in the sample
using RC DC protein assay kit (Bio-Rad) and used dilutions of BSA as the
standard. Total protein samples were separated by SDS-PAGE according
to the previously described method (Ballabh et al., 2007). Equal amounts
of protein (10 –20 g) were loaded into 4 –15% gradient precast gel (Bio-
Rad). The separated proteins were transferred onto PVDF membrane by
electro-transfer. The membranes were then incubated with primary an-
tibodies. We detected target proteins with chemiluminescence ECL sys-
tem (GE Healthcare) by using secondary antibodies conjugated with
horseradish peroxidase (Jackson Immunoresearch). We next stripped
the blots with stripping buffer (Pierce) and incubated with -actin pri-
mary antibody followed by secondary antibody and detection with
chemiluminescence ECL system. As described previously (Ballabh et al.,
2007), the blots from each experiment were densitometrically analyzed
using ImageJ. The optical density (OD) values were normalized by taking
the ratio of the target protein and -actin. The optical density was mea-
sured for of all bands together in each lane for both myelin basic protein
(12–32 kDa) and myelin-associated glycoprotein (MAG) (55– 65 kDa).
For BMP4, however, we measured OD of both BMP precursor (50 kDa)
and BMP mature from (23 kDa) separately and together.
Quantitative real-time PCR. Quantitative real-time PCR (RT-PCR) was
performed as described previously (Ballabh et al., 2007). Briefly, total RNA
were isolated from a 1-mm-thick slice taken at the level of midseptal nucleus
of the forebrain using Mini RNA isolation kit (Zymo Research). RNA was
reverse-transcribed using Superscript II RT (Invitrogen). Real-time reverse
transcriptase-PCR was used to analyze mRNA expression using the
Stratagene MX3000. Quantification was performed using the efficiency-
corrected CT method. The following primers were used for
qRT-PCR: BMP2 sense GGTGGAATGACTGGATTG antisense GCATC-
GAGATAGCACTG; BMP4 (accession #AF042497) sense TTAACCTCAG-
CAGCATCC, antisense CAGTCTCGTGTCCAGTAG; Olig1 sense
CAGCAGCAGCAACTAAGG, antisense GAGTAGGGCAGGATGACC;
Olig2 (accession #NM_005806) sense 5-GTGCGGATGCTTATTATAG-
3, antisense 5-ATCTGGATGCGATTTGAG-3; Id2 (NM_002166) sense
5-AATCCTGCAGCACGTCATCGACTA-3, antisense 5-TGATGCAG-
GCTGACAATAGTGGGA-3; Id4 (accession #NM_001546) sense
5-GGCATAATGGCAAATCCTTCAAG-3, antisense 5-TCACAA-
GAGATGGGACAGTAGC-3.
Electron microscopy. We processed brains (day 14) from glycerol-
treated pups without IVH, and noggin-treated and vehicle-treated pups
with IVH (n  3– 4 each). We cut slices (2 mm thickness) from freshly
harvested rabbit pup brain using a brain slicer matrix and then dissected
the brain slice floating in PBS in a silicone-coated (Slygard; Precision
Instruments) Petri dish under a SteReo discovery microscope (Carl
Zeiss). The dissected corona radiata and corpus callosum of the white
matter were fixed into 2.5% glutaraldehyde overnight. The tissues were
then washed in 0.1 mol/L sodium cacodylate buffer, pH 7.4, postfixed in
buffered osmium tetroxide for 1–2 h, stained en bloc with 1% uranyl
acetate, dehydrated in graded ethanol solutions, and then embedded in
epoxy resin. Sections of 60 –90 nm thicknesses were placed onto 200
mesh grids, stained with uranyl acetate and lead citrate, and then were
examined with a Techni 12 electron microscope at 80 Kv. Digital images
were taken using a 16 megapixel Advanced Microscopy Techniques cam-
era. We acquired 12–20 images per brain region for a total of 270
images (3 groups  3– 4 brain each group  2 brain regions  12–20
images  270 images). Electron micrographs were evaluated for myelin-
ated axons per unit area; and g-ratio (ratio of axonal diameter with
myelin sheath and axonal diameter without myelin sheath) of myelinated
axons in the 3 groups of pups were determined using image processing
software, ImageJ (NIH).
Neurobehavioral assessment. We performed neurobehavioral assess-
ment at postnatal day 14 based on the previously described scoring pro-
tocol (Georgiadis et al., 2008; Chua et al., 2009). The evaluation was
performed by two physicians, who were blinded to the group assignment.
We tested cranial nerves by testing smell (aversive response to ethanol),
sucking and swallowing (formula delivered by a plastic pipette). We
scored the responses on a scale of 0 –3, 0 being the worst response and 3
the best. Motor evaluation included tone (modified Ashworth’s scale),
motor activity, locomotion at 30° angle, righting reflex and gait. Tone
was examined by active flexion and extension of forelegs and hind legs
(score 0 –3). The righting reflex was evaluated by the ability and rapidity
to turn prone when placed in supine position. Sensory evaluation in-
cluded touch on face (touching face with cotton swab) and extremities as
well as pain on limbs (mild pin prick). Grading of tone, gait, and loco-
motion at 30°angle are illustrated in the footnote of Table 1. To test
coordination and muscle strength in forelegs and hind legs, we evaluated
the ability of the pups to hold their position on a ramp pitched at a slope
of 60°. The test was conducted on a rectangular surface (18  6 inch) kept
at 60° inclination. We placed the pup at the upper end of the inclination
and measured the latency to slip down the slope. We performed the visual
cliff test to assess the vision. All animals could detect the cliff.
Statistics and analysis. Data are expressed as means and SEM. To de-
termine differences in the apoptosis, proliferation, caspase-3 activity be-
tween rabbit pups with and without IVH, two-way ANOVA was used.
Table 1. Neurobehavioral evaluation of noggin-treated pups compared to vehicle-








Cranial nerve Aversive response to alcohol 3 (3, 3) 3 (3, 3) 3 (3, 3)
Sucking and swallowing 3 (3, 3) 3 (3, 3) 3 (3, 3)
Vision 3 (3, 3) 3 (3, 3) 3 (3, 3)
Motor Motor activity
Head 3 (3, 3) 3 (3, 3) 3 (3, 3)
Fore legs 3 (3, 3) 3 (3, 3) 3 (3, 3)
Hind legs 3 (3, 3) 3 (3, 3) 3 (2, 3)*
Righting reflexa 5 (5, 5) 5 (5, 5) 3 (3, 5)
Locomotion on 30° inclinationb 3 (3, 3) 3 (3, 3) 3 (2, 3)
Tonec
Forelimb 0 (0, 0) 0 (0, 0) 0 (0, 0)
Hindlimb 0 (0, 0) 0 (0, 0) 0 (0, 0)
Hold their position at 60°
inclination (latency to slip
down the slope in seconds)
13.1 15.3 10.9**
Distance walked in 60 s, inches 101 103 68***
Gaitd 4 (4, 4) 4 (4, 4) 3.5 (2.0, 4)****
Motor impairment Weakness in extremities, % 0% 7.1% 28.6%
Sensory Facial touch 3 (3, 3) 3 (3, 3) 3 (3, 3)
Pain 3 (3, 3) 3 (3, 3) 3 (3, 3)
Values are median and interquartile range. Zero is the worst response, and 3 is the best response.
aScore (range, 1–5): no. of times turns prone within 2 s when placed in supine out of five tries.
bScore (range, 0 –3): 0, does not walk; 1, takes a few steps (less than 8 inches); 2, walks for 9 –18 inches; 3, walks very
well beyond 18 inches.
cScore (range, 1–3): 0, no increase in tone; 1, slight increase in tone; 2, considerable increase in tone; 3, limb rigid in
flexion or extension.
dGait was graded as 0 (no locomotion), 1 (crawls with trunk touching the ground for few steps and then rolls over),
2 (walks taking alternate steps, trunk low and cannot walk on inclined surface), 3 (walks taking alternate steps,
cannot propel its body using synchronously the hind legs, but walks on 30° inclined surface), 4 (walks, runs, and
jumps without restriction, propels the body using synchronously the back legs, but limitation in speed, balance, and
coordination manifesting as clumsiness in gait), or 5 (normal walking).
*p  0.03, **p  0.05, ***p  0.039, ****p  0.04 for the comparison between IVH- and noggin-treated IVH
pups.
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The independent factors in two-way ANOVA
were postnatal age (d3 vs d7) and presence of
IVH treatment (IVH vs no IVH). To assess dif-
ferences in density of pre-OLs and immature
OLs, two-way ANOVA with repeated measures
was used. The repeated measures were applied
to the three white matter regions— corona ra-
diata, corpus callosum, and internal capsule.
For Western blot analyses data, four group
comparisons were done using one-way
ANOVA. All post hoc comparisons to test for
differences between means were done using
Tukey multiple-comparison test at the 0.05 sig-
nificance level.
Results
IVH induces apoptosis and suppresses
proliferation of OL progenitors
As IVH results in neural cell death (Geor-
giadis et al., 2008) and influences neural
cell proliferation (Xue et al., 2003), we in-
vestigated the relative contributions of cell
death and cell proliferation to the total
pool of OLs at successive time intervals
after IVH in our rabbit pup model (Bal-
labh et al., 2007; Georgiadis et al., 2008;
Chua et al., 2009). Double labeling of the
brain sections for TUNEL and O4 antigen
showed that the apoptosis of O4() cells
was significantly more abundant in the
corpus callosum and corona radiata of
pups with IVH compared with glycerol-
treated controls without IVH at both
postnatal days 3 ( p  0.032 and 0.04) and
7 ( p  0.05 and 0.007) (Fig. 1B,C). In the
internal capsule, however, the density of
apoptotic O4 () OLs and also other neural cells did not differ
between pups with and without IVH. The absence of substantial
cell death in the internal capsule, unlike the other white matter
regions, was attributed to the distant anatomical location of this
brain region from the blood filled ventricle. Accordingly, density
of all TUNEL-positive cells in the corona radiata and corpus
callosum were also higher at days 3, 7, and 14 in pups with IVH
compared with pups without IVH ( p  0.05 each, data not
shown). Because O4 labeling at day 14 was inconsistent and vari-
able in the white matter regions, the evaluation of O4-positive cell
death at this age was excluded from the present study. We next
tested apoptosis of mature OLs by combining TUNEL staining
with APC (CC1 clone) immunolabeling. We found that apopto-
tic APC () OLs were relatively scarce (2.7  1.2/mm 2 vs none in
pups with and without IVH) in pups with IVH (Fig. 1D).
To further confirm apoptotic activity in the forebrain of pups
with IVH as a function of postnatal age, we measured caspase-3
expression at postnatal days 3, 7, and 14 by Western blot analysis
(Fig. 1E). The results showed that the expression of cleaved
capsase-3 (active caspase-3, 12 kDa) was higher in pups with IVH
compared with controls without IVH (glycerol treated) at both days
3 and 7 ( p0.001 and 0.022), but not at day 14 ( p0.96) (Fig. 1F).
The findings indicate that apoptotic cell death in IVH pups might be
caspase dependent at both days 3 and 7.
We next assessed proliferation of OL progenitors in the pups
with and without IVH (glycerol-treated). As OL progenitors in
the white matter originate from the VZ and SVZ of human fetuses
(17–23 weeks) and since terminally differentiated OL typically do
not proliferate after completion of their migration (Rakic and
Zecevic, 2003), we assessed proliferation of all neural cells and OL
progenitors in the VZ and SVZ at both days 3 and 7 (Fig. 2). To
label OL progenitors, we used Olig2-, PDGFR-, and O4-specific
antibodies. Olig2 is expressed by both OL progenitors and ma-
ture OL, PDGFR antibody identifies early OL progenitors, and
O4 antibody labels both late progenitors and other OLs. Double
labeling of the brain sections with Olig-2 and Ki67 (proliferation
marker) antibodies showed that the density of proliferating Olig2
() cells was reduced in pups with IVH than pups without IVH
(glycerol treated) at postnatal days 3 ( p  0.001), but not at day
7 (Fig. 2A,B). Accordingly, density of proliferating PDGFR-
positive OLs was less in pups with IVH compared with pups
without IVH at day 3 ( p  0.05), but not at day 7 (Fig. 2C,D).
However, mitotically active O4-positive OLs were comparable
between pups with and without IVH at both days 3 and 7 (Fig.
2E,F). In addition, the development of IVH significantly sup-
pressed the proliferation of all neural cells (all Ki67  cells) in the
lateral VZ and SVZ at both postnatal days 3 and 7 ( p  0.001
each). Proliferating OL in the white matter were scarce at days 3
and 7. Together, IVH-induced apoptotic cell death in the
periventricular white matter and a transient suppression in the
proliferation of OL progenitors in the VZ and SVZ.
IVH arrests maturation of oligodendrocyte lineage in
preoligodendrocyte stage
The findings that IVH-induced apoptosis and inhibited the pro-
liferation of periventricular OL progenitors led us to the question
Figure 2. IVH suppresses proliferation of oligodendrocyte progenitors. A, Cryosections from the forebrain of rabbit pups were labeled
with Olig2 and Ki67 antibody. Cells double labeled for the two antibodies indicate proliferating OLs (arrowhead). B, The bar graph depicts
meanSEM (n5– 6 each). The density of proliferating Olig2 cells in VZ and SVZ was reduced in pups with IVH than without IVH at day
3, not day 7. C, Representative immunofluorescence of cryosections from 3-d-old E29 pups with and without IVH double labeled for
PDGFR- and Ki67-specific antibody. Cells colabeled with the two antibodies indicate proliferating PDGFR-positive OLs (arrowheads).
Note proliferating PDGFR-positive OL in pups without IVH, but not in pups with IVH. D, The bar graph depicts mean  SEM (n  5– 6
each). The density of mitotically active PDGFR cells in VZ and SVZ was reduced in pups with IVH than without IVH at day 3, but not at day
7. E, Cryosections from 3-d-old E29 pups were labeled with O4- and Ki67-specific antibodies. Cells colabeled with the two antibodies
indicate proliferating O4-positive OLs (arrowheads). F, The bar graph depicts meanSEM (n5– 6 each). The density of proliferating O4
() cells was comparable in pups with and without IVH. Insets show immunolabeling under high magnification. Scale bar, 50m. *p
0.05 ***p  0.001 for the comparison between pups with and without IVH.
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of whether the density of early OL progenitors (PDGFR),
pre-OLs (O4 and O1-) and immature OLs (O4 and O1)
differed in the white matter regions of premature pups with
IVH compared with controls (glycerol-treated) without IVH. To
this end, we labeled the brain sections with PDGFR, O4
(biotinylated)-, and O1-specific antibodies (Fig. 3A). We found
that early OL progenitors (PDGFR) were comparable be-
tween pups with and without IVH in the white matter regions at
both days 3 and 7 (Fig. 3B). However, the density of pre-OLs was
higher in the corpus callosum and corona radiata by 20% ( p 
0.017 and 0.006), but not in the internal capsule, of pups with
IVH compared with pups without IVH at day 3 (Fig. 3B). At day
7, pre-OLs were also more abundant in the corpus callosum ( p 
0.029) of pups with IVH relative to pups without IVH, but not in
the corona radiata and internal capsule ( p  0.8 and 0.6) (Fig.
3B). More importantly, the density of immature OL (O4O1)
was significantly reduced in rabbit pups with IVH compared with
pups without IVH at both days 3 ( p  0.001, 0.002) and 7 ( p 
0.007, 0.003) in the corpus callosum and corona radiata, unlike
the internal capsule ( p  0.25, 0.15) (Fig. 3B). A difference in the
impact of IVH on the maturational changes in the pre-OLs and
immature OLs among the white matter regions was ascribed to
their location relative to the ventricle. Collectively, the data sug-
gested that arrested maturation of OL lineage at the pre-OL stage
in pups with IVH resulted in two histological changes—reduc-
tion in the density of immature OLs (myelinating OLs) and the
resultant abundance of pre-OL (nonmyelinating OL).
IVH induces distinct changes in bHLH
transcription factors
While Olig1, Olig2, and Sox10 favor OL
maturation, Id2 and Id4 have inhibitory
influences (Nicolay et al., 2007). We as-
sessed expression of these factors in a cor-
onal slice at the level of midseptal nucleus
in pups with and without IVH (glycerol
treated) at postnatal days 1, 3, 7, and 14 by
real-time quantitative PCR (Fig. 4A).
Olig2 expression was significantly reduced
in pups with IVH relative to pups without
IVH at days 3, 7, and 14 ( p  0.002, 0.025,
and 0.007, respectively), but not at day 1
( p  0.137). Olig1 expression, albeit low
in IVH pups, was not significantly re-
duced in pups with IVH compared with
those of controls at any of the postnatal
days. Sox10 expression was substantially
reduced in pups with IVH relative to con-
trols at days 1, 3, 7, and 14 ( p  0.008,
0.001, 0.002, and 0.025, respectively).
Conversely, Id4 mRNA expression was
significantly elevated in pups with IVH
compared with controls without IVH at
days 1 and 3 ( p  0.001, 0.004), but not at
days 7 and 14 ( p  0.09, 0.8). Id2 mRNA
accumulation was also higher in pups
with IVH compared with controls at day 1
( p  0.02), but not at days 3, 7, and 14
( p 	 0.4 at all time points).
We next measured protein levels of
Olig1 and Olig2 by Western blot analyses.
Consistent with mRNA expression, Olig2
levels were less in pups with IVH com-
pared with pups without IVH at days 7
and 14, but not at day 3 (Fig. 4B). Olig1 levels were comparable
between pups with and without IVH. A reduction in the expres-
sion of Olig2, but not Olig1, in IVH is consistent with the previ-
ous reports on animal models of acute brain injury (Buffo et al.,
2005). Together, induction of IVH elevated inhibitory and sup-
pressed activating transcription factors involved in the specifica-
tion and maturation of OL lineage, consistent with arrested
maturation of pre-OLs in the previous experiment.
High bone morphogenetic protein levels in premature rabbits
with IVH
BMP overexpression diverts OL progenitors to astrocyte lineage,
promotes astrocytosis, and inhibits OL differentiation by down-
regulating Olig1 and Olig2 transcription factors (Nicolay et al.,
2007). Therefore, we assessed BMP2 and BMP4 levels in the fore-
brain of rabbit pups with and without IVH. BMP2 mRNA accu-
mulation was significantly higher in pups with IVH than
glycerol-treated controls without IVH at day 3, 7, and 14 ( p 
0.05, 0.002, 0.001), but not at day 1 ( p  0.8) (Fig. 5A). In
addition, the BMP2 level increased as a function of postnatal age
in pups with IVH ( p  0.001), but not in controls without IVH.
However, Western blot analysis revealed that BMP2 protein (pre-
cursor: 60 kDa, mature: 20 kDa) levels were comparable between
pups with and without IVH (Fig. 5B). Accordingly, immunohis-
tochemistry showed that BMP2 immunoreactivity was compara-
ble between pups with and without IVH. BMP2 was weakly
expressed in the ependyma and Tuj1 () neuronal progenitors of
Figure 3. IVH induces maturation arrest of pre-OL and affects Olig2, SOX10, and Id4 transcription factors. A, Representative
double immunolabeling of the cryosections from the forebrain of pups with IVH using a combination of O4 with O1 or PDGFR
antibody at day 3. Note that pre-OLs are labeled with O4, not with O1 antibody (arrows), and immature OL are labeled with both
O4 and O1 (arrowheads). Note that O4 () cells (arrowhead) mostly do not overlap PDGFR () OL (arrow). Insets show O4, O1,
and PDGFR immunolabeling under high magnification. Scale bar, 25 m. B, The data in the bar charts represent mean  SEM
(n5– 6 each). At both day 3 and 7, the density of PDGFR () OL was comparable between pups with and without IVH in corpus
callosum (CC), corona radiata (CR), and internal capsule (IC). However, the pre-OLs (O4O1
) were more abundant in the CC and
CR of pups with IVH than without IVH at day 3, but not in the IC. At day 7, pre-OLs were more in number in the CC of IVH pups relative
to pups without IVH, but not in the CR and IC. The density of immature OL (O4O1) was significantly reduced in rabbit pups with
IVH than in pups without IVH at both day 3 and 7 in the corpus callosum and corona radiata, unlike the internal capsule. ***p 
0.001, **p  0.01, and *p  0.05 for the comparison between pups with and without IVH in corpus callosum. #p  0.05 for the
comparison between pups with and without IVH in corona radiata.
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the SVZ. However, BMP2 was strongly expressed in cortical neu-
rons particularly in neuropils of the cerebral cortex (Fig. 5C). The
discrepancy between protein and mRNA abundance of BMP2 in
pups with IVH can be attributed to either post-transcriptional or
post-translational factors. Accordingly, BMP2 levels were similar
in human premature infants with and without IVH in the three
brain regions— cortex, white matter and germinal matrix— on
Western blot analysis (Fig. 5D).
Real time PCR revealed that BMP4 mRNA expression was
greater in pups with IVH relative to controls at days 3, 7 and 14
( p  0.003, 0.001, and 0.001 respectively), but not at day 1 ( p 
0.646) (Fig. 6A). BMP4 levels also increased with the advancing
postnatal age in pups with IVH, unlike controls ( p  0.001).
Consistent with mRNA levels, the expression of BMP4 protein
[both precursor (50 kDa) and mature (23 kDa) form] measured
by Western blot analyses, was higher in pups with IVH than in
glycerol-treated controls without IVH at days 3, 7 and 14 ( p 
0.044, 0.001, and 0.012) (Fig. 6B). The levels of mature BMP4
form (23 kDa) alone were also significantly higher in pups with
IVH compared with controls at day 7 and 14 ( p  0.02 and
0.017), but not at day 3. Immunostaining showed that BMP4
expression was more abundant in the VZ, SVZ, and adjacent
white matter of rabbit pups with IVH compared with controls
without IVH (Fig. 6C). BMP4 was strongly expressed in Tuj1()
neuronal precursors of the SVZ, MAP2 () neurons of the cere-
bral cortex and white matter, as well as APC () OL in the white
matter. The immunoreactivity on these neural cells were stronger
in pups with IVH than controls without IVH. BMP4 immunore-
activity was weak-to-absent in the glial fibrillary acidic protein
(GFAP)-positive astrocytes. Together, IVH-induced upregula-
tion of BMP4 in premature rabbit pups.
High bone morphogenetic protein expression in premature
humans with IVH
To determine whether human premature infants with IVH de-
velop similar elevation in BMP4 secondary to IVH as those of
rabbit pups, we evaluated postmortem human materials for
BMP4 expression. Immunolabeling revealed that BMP4 expres-
sion was more abundant in the VZ, SVZ, and the subjacent white
matter of infants with IVH compared with controls without IVH
(Fig. 7A). Immunoreactivity to BMP4 was noted in the Tuj1 ()
neuronal precursors of the SVZ, MAP2 () neurons of the cor-
tex, Olig2 () and NG2 () cells of the white matter and SVZ
(Fig. 7A). BMP4 was moderately expressed by GFAP () astro-
cytes in SVZ and adjacent white matter of premature infants of
23–26 week with IVH, and weakly in this groups of infants with-
Figure 4. IVH distinctly affects the bHLH transcription factors. A, The data are meanSEM (n 6 at each time point). Olig1 gene expression was not different in pups with and without IVH. Olig2
expression was significantly lower in pups with IVH than in pups without IVH at days 3, 7, and 14, but not at day 1. Sox10 expression was significantly lower in pups with IVH than in pups without
IVH on all days. Id2 mRNA levels were higher in pups with IVH than pups without IVH at day 1, but not on other days. Id4 mRNA expression was significantly greater in pups with IVH compared with
pups without IVH at days 1 and 3, but not at day 7 and 14. ***p0.001, **p0.01, and *p0.05 for the comparison between pups with and without IVH. B, Representative Western blot analyses
for Olig2 and Olig1 in the forebrain of premature rabbit pups with and without IVH at postnatal days 3, 7, and 14. Each lane represents lysate from whole coronal slice taken at the level of midseptal
nucleus of one brain. Rat brain was taken as positive control. Values are normalized to -actin levels. Bar chart shows mean  SEM (n  6 each). Olig2 levels were significantly lower in rabbit pups
with IVH compared with controls at days 7 and 14, but not at day 3. However, Olig1 levels were comparable between pups with and without IVH at days 3, 7, and 14. **p  0.01 and *p  0.05 for
the comparison between pups with and without IVH.
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out IVH. Western blot analyses revealed that BMP4 protein [both
precursor (50 kDa) and mature (23 kDa) form] levels were sig-
nificantly higher in the VZ and SVZ (germinal matrix, p  0.048)
as well as in the white matter ( p  0.014) of the infants with IVH
relative to infants without IVH, but not in the cerebral cortex
( p  0.07) (Fig. 7B). The levels of mature BMP4 form (23 kDa)
alone were also significantly elevated in white matter of prema-
ture infants with IVH compared with infants without IVH ( p 
0.02), but not in the germinal matrix ( p  0.07) and cerebral
cortex ( p  0.12). In contrast to BMP4, BMP2 protein levels
were similar in the cortex, white matter, and germinal matrix of
premature infants with and without IVH (data not shown). To-
gether, the data suggested that the development of IVH triggered
upregulation of BMP4 in the forebrain of premature infants just
as in the rabbit pups.
Intracerbroventricular infusion of noggin alleviates
neurological impairment
To determine whether noggin treatment attenuates neurological
impairment, we performed a neurobehavioral evaluation among
three sets of premature rabbit pups at postnatal day 14 based on
our previously described scoring system (Chua et al., 2009): (1)
glycerol-treated pups without IVH; (2) pups with IVH treated
with ICV noggin; and (3) pups with IVH treated with ICV vehicle
(Table 1). The severity of IVH, measured by head ultrasound, in
noggin-treated pups was similar to those of vehicle-treated con-
trols. The seven day course of noggin or vehicle treatment was
initiated at 24 h age because BMP levels were elevated in pups
with IVH at all days—3, 7 and 14 and since maturation arrest of
OLs was noted at both days 3 and 7.
We noted significant weakness in the forelegs of one and the
hind legs of three vehicle-treated pups with IVH (28.6%),
whereas one pup in the noggin-treated group (7%) had weakness
in the left hind-leg manifesting adduction, internal rotation of
the back leg and asymmetry in gait. The average scores for gait
were substantially better in noggin-treated pups than in vehicle-
treated controls ( p  0.04). The motor activity of the back legs—
capability to lift the trunk and pelvis—was also better in treated
pups compared with vehicle controls ( p  0.03). The mean dis-
tance walked in 60 s was longer in noggin-treated pups relative to
Figure 5. Effect of IVH on BMP2 levels. A, The data are mean  SEM (n  6 each time point). BMP2 mRNA accumulation was significantly higher in pups with IVH than glycerol-treated pups
without IVH at days 3, 7, and 14, but not at day 1. In addition, BMP2 level increased as a function of postnatal age in pups with IVH, but in controls without IVH. B, Representative Western blot analyses
for BMP2 in premature rabbit pups with and without IVH at postnatal days 3, 7, and 14. Rat brain was used as positive control (Ctrl). Each lane represents lysate from whole coronal slice taken at the
level of midseptal nucleus of one brain. Values are normalized to -actin levels. The bars are mean  SEM (n  6 each time point). BMP2 expression was comparable in rabbit pups with IVH and
glycerol-treated controls without IVH on days 3, 7, and 14. C, Representative immunofluorescence of cryosections from a 3-d-old pup labeled with a combination of BMP2 with Tuj1- or MAP-2-
specific antibody. BMP2 was weakly expressed in the ependyma and Tuj-1 () neuronal precursor cells of SVZ. In the cerebral cortex, BMP2 immunoreactivity was noted in MAP2 () neurons
(arrowheads). Scale bar, 50 m. D, Representative Western blot analyses for BMP2 in human premature infants with and without IVH. Values are normalized to -actin levels. The bars are mean 
SEM (n  6 each time point). BMP2 expression in the germinal matrix (GM) (VZ and SVZ), white matter (WM), and cerebral cortex was comparable in infants with and without IVH.
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vehicle controls ( p  0.039). The latency to slip down a ramp
pitched at a slope of 60° was substantially longer in duration in
noggin-treated pups compared with vehicle controls ( p  0.05).
The tone in the back legs of two pups with motor impairment in
the vehicle-treated group was slightly increased (score  1). No
differences were noted in sensory and cranial nerves in the three
sets of rabbit pups. Importantly, we did not observe any apparent
adverse effect attributable to noggin treatment among pups with
IVH receiving this medication. Together, noggin-treated pups
with IVH exhibited better neurobehavioral score than vehicle-
treated controls with IVH.
Noggin treatment blocks BMP signaling, enhances
myelination
To confirm the blocking of BMP signaling by noggin treatment,
we measured phospho-Smad1 (Ser463)/Smad5 (Ser463/465)/
Smad8 (Ser426/428) levels in the forebrain of (1) noggin-treated
pups with IVH, (2) vehicle-treated pups with IVH, and (3) pups
without IVH (glycerol treated). We found that phospho-Smad1/
5/8 levels, measured by Western blot analyses, were significantly
elevated in rabbit pups with IVH compared with controls with-
out IVH ( p  0.001), suggesting enhanced BMP signaling in
rabbit pups with IVH. Importantly, noggin treatment signifi-
cantly reduced phosho-Smad1/5/8 in rabbit pups with IVH ( p 
0.001) (Fig. 8A). Hence, the induction of IVH enhanced BMP
signaling; and noggin treatment blocked BMP signaling, which
was consistent with the previous report (Cate et al., 2010).
We next assessed expression of MBP in four sets of P14 rabbit
pups: (1) glycerol-treated pups without IVH; (2) glycerol-treated
pups with IVH; (3) ICV noggin-treated pups with IVH; and (4)
ICV vehicle-treated pups with IVH. We performed stereological
quantification of myelin on brain sections stained with MBP an-
tibody and Western blot analyses on homogenates from a brain
slice taken from the forebrain at the level of midseptal nucleus.
Stereological analyses showed that the volume fraction (load) for
MBP in the corpus callosum was higher in noggin-treated pups
Figure 6. IVH induces elevation of BMP4 in rabbit pups. A, The data are mean  SEM (n  6 each time point). Both BMP4 mRNA accumulation was significantly higher in pups with IVH than
glycerol-treated pups without IVH at days 3, 7, and 14, but not at day 1. In addition, BMP4 levels increased as a function of postnatal age in pups with IVH, but not in controls without IVH. B,
Representative Western blot analyses for BMP4 in premature rabbit pups with and without IVH at postnatal 3, 7, and 14. 293T whole-cell lysate (sc-113395; Santa Cruz Biotechnology) was used as
positive control. Each lane represents lysate from whole coronal slice taken at the level of midseptal nucleus of one brain. Values are normalized to -actin levels. Error bars are mean  SEM (n 
6 each time point). BMP4 expression [both precursor (50 kDa) and mature (23 kDa) together] was higher in rabbit pups with IVH than in glycerol-treated controls without IVH on days 3, 7, and 14.
C, Representative immunofluorescence of cryosections from 3-d-old E29 pups with and without IVH labeled with BMP4 antibody (top). All insets show high-magnification views from the region in
the image indicated by asterisks. Immunoreactivity to BMP4 is more abundant in IVH subjects than controls without IVH. Cryosections are shown from rabbit forebrain (E29 pup of 3 d postnatal age)
double labeled with a combination of BMP4 with Tuj1, MAP2, APC, or GFAP antibodies. BMP4 was expressed by Tuj1-positive neuronal precursors (arrowheads) of the VZ and SVZ, MAP2-positive
neurons (arrowheads) of the cerebral cortex and APC-positive oligodendrocytes (arrowheads) in the white matter. However, BMP4 immunoreactivity was absent on GFAP-positive astrocytes. Scale
bar, 50 m.
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with IVH compared with vehicle-treated and untreated controls
with IVH ( p  0.001 and 0.045) (Fig. 8B). Similarly, the volume
fraction of MBP in the corona radiata was higher in the noggin-
treated pups compared with vehicle-treated controls ( p 
0.005), but not with untreated IVH controls ( p  0.06). Accord-
ingly, Western blot analyses showed that noggin treatment of
pups with IVH significantly enhanced the expression of MBP
compared with vehicle-treated and untreated pups with IVH
( p  0.05 each) (Fig. 8C).
To further confirm the effect of noggin treatment on myeli-
nation, we compared the expression of MAG in noggin-treated,
vehicle-treated, and untreated pups with IVH as well as pups
without IVH. MAG levels were significantly elevated in noggin-
treated rabbit pups with IVH compared with vehicle-treated and
untreated controls with IVH ( p  0.001 both) (Fig. 8D). Collec-
tively, noggin treatment significantly enhanced MBP and MAG
expression in pups with IVH.
Noggin treatment reduces gliosis
We next compared gliosis among four sets of P14 rabbit pups in a
similar fashion as for myelin. GFAP-labeled brain sections were
evaluated by unbiased stereology and quantification of GFAP in
homogenates from brain slice (midseptal nucleus level) was per-
formed by Western blot analyses. For stereological assessment of
gliosis, we performed astrocyte count and measured total volume
fraction of astrocytes and glial fibers in GFAP-labeled brain sec-
tions. We found that there were fewer astrocytes in the corpus
callosum and corona radiata of noggin-treated pups with IVH
compared with vehicle-treated controls with IVH ( p  0.028 for
corpus callosum and 0.017 for corona radiate) (Fig. 9A). Accord-
ingly, the total volume faction (load) of astrocyte cell bodies and
their fibers were significantly reduced in the corpus callosum
( p  0.001 and 0.008 for noggin- vs vehicle-treated or untreated
IVH controls) and corona radiata ( p  0.001 both for noggin- vs
vehicle-treated or untreated IVH controls) of noggin-treated
pups with IVH compared with vehicle-treated and untreated
controls with IVH.
Consistent with stereological evaluation, Western blot analy-
ses revealed that GFAP levels were significantly reduced in
noggin-treated pups compared with vehicle-treated and un-
treated controls ( p  0.001 both) (Fig. 9B). Furthermore, GFAP
levels were comparable between noggin-treated pups with IVH
and controls without IVH. To determine the effect of noggin on
astrocyte proliferation, we double labeled the brain sections from
pups without IVH, with IVH, and with IVH treated with noggin
using Ki67 and GFAP-specific antibodies. We found that noggin
treatment did not affect astrocyte proliferation (data not shown).
Figure 7. IVH induces elevation of BMP4 in premature infants. A, Representative immunofluorescence of cryosections from premature infants (23 week gestation) with and without IVH labeled
with BMP4 antibody (top). Insets show high-magnification views from the region in the image indicated by asterisk. Immunoreactivity to BMP4 is more abundant in IVH subjects than controls
without IVH. Cryosections from 23 week human premature infant were labeled with a combination of BMP4 with Olig2-, Tuj1-, NG2-, or GFAP-specific antibodies. Note BMP4 immunoreactivity in
Tuj1-positive neuronal precursors (arrowheads) of the VZ and SVZ as well as Olig2-positive (arrowheads) and NG2-positive OL. BMP4 was also expressed in GFAP () astrocytes in the white matter
and cortex. Scale bar, 50 m. B, Representative Western blot analyses for BMP4 in postmortem brain samples from premature infants. Values are normalized to -actin levels. Error bars are mean
SEM (n  6 each time point). BMP4 [both precursor (50 kDa) and mature (23 kDa) form] expression was higher in the germinal matrix (GM) (VZ and SVZ) and white matter (WM) of premature infants
with IVH compared with infants without IVH. *p0.05 for the comparison between subjects with and without IVH. Western blot analyses revealed that BMP4 protein levels were significantly higher
in the VZ and SVZ (germinal matrix, p  0.048) as well as in the white matter ( p  0.014) of the infants with IVH relative to infants without IVH, but not in the cerebral cortex ( p  0.07) (Fig. 7B).
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Together, noggin treatment not only enhanced myelination, but
also reduced gliosis in rabbit pups with IVH.
Noggin restores Olig2 and Id4 levels, and enhances
maturation of OL
As BMP signaling suppresses OL maturation by inducing Id2 and
Id4, and suppressing Olig1 as well as Olig2 transcription factors
(Samanta and Kessler, 2004), we hypothesized that the BMP an-
tagonist, noggin, would restore levels of Olig1 and Olig2 tran-
scription factor. We found that Olig2 mRNA expression was
significantly higher in noggin-treated pups compared with vehi-
cle controls at days 3 and 7 ( p  0.047 and 0.002), but not at day
14 ( p  0.7) (Fig. 10A). Accordingly Id4 mRNA abundance was
substantially lower in all noggin-treated pups relative to vehicle
controls ( p  0.011) when all subjects at three time points— days
3, 7 and 14 —were combined. However, difference between the
two groups at any particular time point (days 3, 7, or 14) was not
significant ( p  0.19, 0.06, 0.47). Accordingly, Sox10 levels
trended higher at days 3 and 7 in treated pups relative to vehicle
controls, however the statistical comparison was not significant.
Olig1 and Id2 gene expression were comparable between the two
groups. As IVH-induced Id4 and to a lesser extent Id2 (only at day 1),
as well as suppressed Sox10, Olig2, but not Olig1, noggin treatment
seemingly offsets the levels of only those transcription factors that are
altered in pups with IVH. Collectively, noggin treatment restored
Olig2 and Id4 transcription factors in pups with IVH.
We next compared the density of pre-OL and immature OLs
between noggin- and vehicle-treated pups with IVH. Double immu-
Figure 8. Noggin treatment restores phospho-Smad1/5/8 and enhances myelination. A, Phospho-Smad1/5/8 elevated in IVH and noggin treatment reduced its expression. Representative
Western blot analyses for phospho-Smad1/5/8 in the forebrain of noggin- and vehicle-treated pups with IVH as well as pups without IVH. Each lane represents lysate from whole coronal slice taken
at the level of midseptal nucleus of one brain. Positive control (Ctrl) was lysate made from rat glial C6 cells treated with BMP4. The data are mean  SEM. Phospho-Smad1/5/8 expression was
significantly higher in rabbit pups with IVH compared with pups without IVH; and noggin treatment reduced phospho-Smad1/5/8 levels in pups with IVH. ***p  0.001 for the comparison between
pups with and without IVH. ###p  0.001 for the comparison between noggin-treated and vehicle-treated pups with IVH. Gly, Glycerol. B, Representative immunofluorescence of cryosections from
14-d-old pups labeled with MBP-specific antibody. Note reduced immunoreactivity to MBP in periventricular zone (corona radiata) of pups with IVH and restoration of myelin in noggin-treated pups.
Error bars are meanSEM (n5– 6 each time point). Volume fraction of MBP was higher in corpus callosum (CC) of noggin-treated pups compared with vehicle-treated and untreated control pups
with IVH. Volume fraction of MBP in the corona radiata was also more abundant in the noggin-treated pups than in vehicle-treated controls, but not in untreated IVH controls. Scale bar, 100 m.
V, ventricle. C, Representative Western blot analyses for MBP in the forebrain of premature rabbit pups in four sets of pups as indicated. A healthy mouse brain was used as positive control. Each lane
represents lysate from whole coronal slice taken at the level of midseptal nucleus of one brain. Error bars are mean  SEM (n  5– 6 each group). MBP expression was higher in noggin-treated pups
compared with vehicle-treated pups. D, Representative Western blot analyses for MAG in the forebrain of premature rabbit pups in four sets of pups as indicated. Rat brain was used as positive
control. The data in the bar diagram are mean  SEM (n  6 each group). MAG expression was higher in noggin-treated pups compared with vehicle-treated and untreated pups with hemorrhage.
***p  0.001, **p  0.01, and *p  0.05 for the comparison between noggin-treated pups and vehicle-treated pups. ###p  0.001 and #p  0.05 for the comparison between noggin-treated
pups and untreated pups.
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nostaining with O4 and O1 antibodies showed that pre-OLs at day 3
were fewer in the corona radiata of noggin-treated than vehicle-
treated pups ( p  0.001), but not in the corpus callosum and inter-
nal capsule ( p  0.143, 0.562) (Fig. 10B). At day 7, density of pre-OL
was comparable between noggin- and vehicle-treated pups with IVH in
all the three white matter regions. Importantly, immature OLs were
more abundant in noggin-treated pups compared with vehicle-treated
pups at both day 3 ( p  0.001, 0.001, and 0.032) and day 7 ( p  0.001,
0.001,and0.009)(Fig.10B) inall the threebrainregions.This suggested
thatnoggintreatmentaugmentedmaturationofpre-OLintoimmature
OL, leading to a reduction in the density of pre-OL.
We next assessed proliferation of Olig2 () cells in noggin-
treated IVH pups compared with vehicle-treated controls by double
labeling sections with Olig2 and Ki67 antibody. We found that nog-
gin treatment did not affect proliferation of Olig2 () cells in the
SVZ of IVH pups compared with vehicle controls at day 3 (142.8 
26.8 vs 132.5  10.0, p  0.7), which is consistent with the previous
report (Cate et al., 2010). To determine an effect of noggin treatment
on OL population in healthy animals, we alternately treated healthy
E29 rabbit pups (no IVH) with human recombinant noggin or ve-
hicle for 3 d. The density of Olig2-positive cells was comparable
between noggin- and vehicle-treated pups without IVH at day
3, suggesting that noggin treatment in healthy animals may
not affect OL population (Fig. 10C).
As posthemorrhagic hydrocephalus is an important outcome of
IVH in our animal model, just like premature infants, we asked
whether placement of ICV cannula affected ventriculomegaly in the
ICV noggin- and ICV vehicle-treated rabbit pups compared with
untreated controls. Based on our previous study (Chua et al., 2009),
ventriculomegaly was defined as a ventricular area that measures 	3
SD above the mean for age in non-IVH pups. The incidence of
ventriculomegaly was 7% in noggin-treated, 14% in vehicle-treated
and 40% in untreated rabbit pups. The reduction in ventriculo-
megaly in noggin- and vehicle-treated in contrast to the untreated
pups suggested that indwelling ICV cannula decompressed the lat-
eral ventricle. To confirm the CSF leakage around the ICV cannula,
we infused two rabbit pups with Evan’s blue using the osmotic
pumps. Blue staining on the surface of the cerebral cortex and peri-
osteal surface around the cannula suggested decompression of the
ventricle by the ICV cannula in vehicle- and noggin-treated pups.
Together, noggin treatment did not affect cerebral ventricle size, but
the placement of the ICV cannula reduced the ventricle size.
Noggin treatment enhances density of myelinated axons in
pups with IVH on ultrastructural study
To determine morphological recovery in myelination upon nog-
gin treatment in pups with IVH, we evaluated myelin at ultra-
structural level in 3 sets of pups: a) glycerol-treated pups without
Figure 9. Noggin treatment reduces gliosis. A, Representative labeling of cryosections from 14-d-old rabbit pups labeled with GFAP antibody. Note abundant hypertrophic astrocytes—with
large cell body and numerous processes making a dense network—in the periventricular zone of pups with IVH (arrowheads) and reduction in number of these astrocytes in noggin-treated pups.
Inset shows hypertrophic astrocytes. The bars are mean  SEM (n  5– 6 each group). Astrocyte count in the corpus callosum (CC) and corona radiata (CR) was less in noggin-treated pups with IVH
compared with vehicle-treated controls with IVH. The total volume fraction of astrocyte cell body and their fibers was less abundant in corona radiata and corpus callosum of noggin-treated pups
with IVH compared with vehicle-treated and untreated control pups with IVH. B, Representative Western blot analyses for GFAP in the forebrain of premature rabbit pups in four groups of pups as
indicated. The data are mean  SEM (n  6 each group). A healthy rat brain was used as positive control. Each lane represents lysate from whole coronal slice taken at the level of midseptal nucleus
of one brain. GFAP expression was lower in noggin-treated pups compared with vehicle-treated and untreated pups. ***p  0.001, **p  0.01, and *p  0.05 for the comparison between
noggin-treated pups and vehicle-treated pups. ###p  0.001 for the comparison between noggin-treated pups and untreated pups. Scale bar, 50 m, K  10 3.
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IVH, b) untreated pups with IVH, and c)
noggin-treated pups with IVH (Fig. 11).
An evaluation of white matter of pups
with IVH revealed that the myelinated
and unmyelinated fibers, in general, were
well organized and preserved, similar to
controls without IVH. However, a few ax-
ons in pups with IVH displayed features
of axonal degeneration, including in-
traaxonal vacuoles and autophagosomes,
which were not seen in pups without IVH.
We did not identify Wallerian-like axonal
degeneration. In addition, remyelinating
axons and very small axons representing
regenerating sprouts were not seen. We
next compared the density of myelinated
axons in the three groups of pups. We
found that myelinated axons were fewer
in pups with IVH compared with controls
without IVH ( p  0.024). In addition,
noggin treatment significantly increased
the number of myelinated axons in pups
with IVH ( p  0.05). However, g-ratio
was comparable in the three groups of
pups (0.77  0.01 vs 0.76  0.001 vs
0.76  0.014, in pups without IVH, with
IVH and noggin-treated respectively).
Usually, axons of larger diameter have
larger g-ratio, that is, they have relatively a
thinner myelin sheath. Together, the den-
sity of myelinated axons is reduced in
pups with IVH, and noggin treatment re-
stored their density.
Discussion
IVH is a major neurological disorder of pre-
mature infants that results in cerebral palsy
and cognitive deficits. As the prematurity
rate is increasing and since the survival of these infants has markedly
improved, neurologic sequelae following IVH is a major public
health concern (Arias et al., 2003; Jain et al., 2009). In this study, we
explored the mechanistic basis of white matter injury in IVH and
exploited a novel strategy to protect the white matter. Specifically, we
found that the induction of IVH in premature rabbit pups
resulted in increased apoptosis, reduced proliferation and matu-
rational failure of OL-lineage cells in the periventricular white matter
and that inhibition of BMP by noggin treatment led to (1) restora-
tion of Olig2 and Id4 transcription factors, (2) maturation of pre-
OL, (3) improved myelination, (4) reduced astrocytosis, and (5)
neurological recovery.
In the present study, IVH resulted in apoptosis, reduced pro-
liferation and maturational failure of OL progenitors. Apoptosis
was associated with significant elevation in capsase-3 at day 3
and 7, but not at day 14. This suggested IVH-associated early
apoptosis to be caspase-dependent and late apoptosis to be
caspase-independent. In our IVH model, we have previously
shown an elevation of caspase-3/7, -8, and -9 activities at 12, 48,
and 72 h of age, indicating activation of both intrinsic and ex-
trinsic apoptotic pathways in IVH (Vinukonda et al., 2010).
Caspase-independent forms of apoptosis at day 14 in our model
might be ascribed to mitochondrial release of apoptosis-
inducing-factor and perhaps of other proteins, as reported in
animal models of focal cerebral ischemic damage (Culmsee et al.,
2005; Krantic et al., 2007). Our finding of reduced neural cell
proliferation in pups with IVH is in agreement with the report in
blood infusion model of IVH in rats (Xue et al., 2003). Impor-
tantly, we noted an elevation in the density of pre-OLs (10 –
20%) in pups with IVH, despite their apoptosis and reduction in
proliferation. We attribute this primarily to arrested maturation
of pre-OL into immature OL resulting in escalation in pre-OL
and reduction in immature OL density. The suppression in OL
proliferation was transient (at day 3, but not at day 7). Thus,
maturational arrest of pre-OL along with their degeneration ap-
pears to be the major event undergoing in the white matter of
pups with IVH. Similar observation of the maturational arrest of
pre-OL has been made in a recent study in a rat model of hypoxia-
ischemia (Segovia et al., 2008) and indicated in a study on
autopsy materials of premature infants with periventricular leu-
komalacia (Billiards et al., 2008). However, hypoxia-ischemia in-
duces rapid proliferation of OL progenitors (Segovia et al., 2008),
in contrast to our IVH model where reduction in mitosis was
noted. The reduction in maturation of OL is unlikely to be related
to a loss of axons because axons are relatively preserved in our
model of IVH. However, we did not exclude the possibility of
modification of proteins in intact appearing axons, which might
affect the differentiation of pre-OLs and axonal myelination
(Haynes et al., 2005). Together, hypomyelination in premature
infants with IVH could be the result of apoptosis and arrested
maturation of OL lineage.
Figure 10. Noggin treatment restores Olig2 and Id4 and enhances OL maturation. A, The data are mean  SEM (n  6 each
group). Olig1, Sox10, and Id2 gene expression were similar between the noggin-treated and vehicle-treated pups with IVH. Olig2
mRNA expression was substantially greater in noggin-treated pups compared with vehicle controls at day 3 and 7, not at day 14.
Id4 mRNA abundance was significantly lower in all noggin-treated pups relative to vehicle controls when all subjects at three time
points— days 3, 7, and 14 —were combined. However, there was no difference between the two groups at any particular time
point. B, The data are mean  SEM (n  6 each group). At day 3, the pre-OLs were fewer in the corona radiata (CR) of noggin-
treated than vehicle-treated pups, unlike corpus callosum (CC) and internal capsule (IC). At day 7, the density of pre-OLs was similar
between two groups of pups—noggin- and vehicle-treated—in all the three white matter regions. The immature OLs were more
abundant in noggin-treated pups compared with vehicle-treated pups at both days 3 and 7 in all the three brain regions. C, The
data are mean  SEM (n  6 each group). The density of Olig2 () OL was comparable between vehicle- and noggin-treated
healthy pups without IVH. ***p  0.001, **p  0.01, and *p  0.05 for the comparison between noggin-treated pups and
vehicle-treated pups.
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A number of studies have revealed that BMP overexpression
inhibits differentiation of OL and diverts OL progenitors to as-
trocyte lineage, thus promoting astrocytosis (Gomes et al., 2003;
Liu and Niswander, 2005; Hampton et al., 2007). Consistent with
these findings, we noted an elevation in BMP4 protein associated
with maturational failure of OL progenitors and gliosis in our
rabbit model of IVH. Accordingly, an elevation in levels of phos-
pho-Smad1/5/8 in rabbit pups with IVH showed more enhanced
BMP signaling in pups with IVH compared with pups without
IVH. Importantly, premature human infants with IVH also ex-
hibited high BMP4 levels compared with infants without IVH. To
our knowledge, this is the first report demonstrating elevation of
BMP4 in an animal model of neonatal brain injury and prema-
ture human infants with IVH. Although human data from au-
topsy materials are invaluable, they have inherent limitations
because of the associated cofounding variables, including me-
chanical ventilation, exposure to a number of prenatal and post-
natal medications, and others. High BMP levels in the brain
region around the ventricle are likely to act locally in the SVZ and
in the subjacent white matter since it binds to the extracellular
matrix, limiting its diffusion through tissues (Hall and Miller,
2004). As OL progenitors in the white matter and cortex originate
from the VZ and SVZ of human fetuses (Rakic and Zecevic,
2003), high BMP in the periventricular white matter could arrest
maturation of OL in the pre-OL stage and augment gliosis in this
brain region. Of note, white matter disease in premature infants
and also in our rabbit model is seen predominantly in the
periventricular white matter (Okoshi et al., 2001). Hence, ar-
rested maturation of OL after IVH appears to be BMP dependent.
Even though BMP4 enhances apoptosis in certain context, apo-
ptosis after IVH appears to be BMP independent.
The most important and novel observation of this study was
the neurological recovery in premature rabbit pups with IVH by
the use of BMP inhibitor, noggin. In fact, this is the first use of
recombinant human noggin as a neuroprotectant in an animal
model of neonatal brain injury. BMP2 and BMP4 are the major
types of BMP expressed in the forebrain; and noggin is an extracel-
lular BMP antagonist that binds with BMP2/4, thereby interfering
with its binding to receptors. BMP4 treatment on cerebral OL pre-
cursor cells reduces MBP and proteolipid protein expression via ac-
tivation of Id-2 and Id-4 and inhibition of Olig1 and Olig2 genes
(Yanagisawa et al., 2001; Cheng et al., 2007); and conversely, over-
expression of BMP antagonist—noggin—in genetically engineered
mice reduces ischemic brain injury by increasing the density of OL
progenitors (Samanta et al., 2010). Furthermore, chordin, a BMP
antagonist, promotes oligodendrogenesis in the SVZ cells in both in
vivo and in vitro experiments (Jablonska et al., 2010). Consistent with
these published data, we found that noggin treatment enhanced the
maturation of pre-OLs into immature OLs and thereby augmented
myelination. In addition, Olig2 levels were significantly elevated and
Id4 expression was more reduced in noggin-treated than in vehicle-
treated control pups in our animal model. Together, the data suggest
that noggin treatment promoted maturation of pre-OLs into my-
elinating OLs by upregulating Olig2 and downregulating Id4
transcription factor, thereby promoting myelination and neuro-
logical recovery.
Another key finding that emerged from our study was that
noggin treatment does not only promote myelination, but signif-
icantly reduces gliosis. Consistent with our finding, it has been
shown in adult rat spinal cord that a local increase in BMPs at the
site of demyelination results in gliosis, glial scar formation and
elevation in the expression of chondroitin sulfate proteoglycans
(CSPG) (Fuller et al., 2007). Heightened expression of CSPGs,
including versican, neurocan and aggrecan, inhibit proliferation
of OLs and myelination (Asher et al., 2002); and conversely, deg-
radation of CSPGs by either chondroitinase or protease facilitates
migration of OLs (Ikegami et al., 2005), loosens the physical bar-
riers in extracellular matrix (Silver and Miller, 2004), enhances
formation of OLs process outgrowths, and improves interaction
between growth factors and OLs (Oh et al., 1999). Hence, neuro-
logical recovery with noggin treatment might be partly attributed
to reduction in gliosis and resultant attenuation of CSPG levels in
the extracellular matrix of the white matter.
Moderate to severe IVH in premature infants results in cere-
bral palsy and cognitive deficits in a large number of the survi-
vors. Even though infrequent, active withdrawal of life support
from premature infants with severe IVH does happen, based on
the quality of life concerns (Sawyer, 2008). At this time, no treat-
ment is available for this disorder. Thus, our study showing clin-
ical recovery in treated pups compared with untreated controls
offers a major strategy that can potentially be translated in patient
treatment. A major hurdle to our approach is the requirement of
intracerebral rather than systemic administration of the medica-
tion to downregulate BMP4 in the brain. However, ventricular
drainage using frontal and occipital catheters, irrigation with ar-
tificial CSF, and fibrinolytic therapy have been tried in a random-
ized clinical trial in premature infants without significant success
(Whitelaw et al., 2007). Hence, intracerebral administration of
BMP inhibitors in the cerebral ventricle of premature infants,
even though invasive and involving risk, is plausible. Systemic use
of small molecule BMP inhibitors that penetrates the blood brain
barrier has not undergone clinical trial for any disease so far
(Hong and Yu, 2009). If intracerebral treatment of noggin proves
to be safe and effective in preventing neurologic sequelae in pre-
mature infants with IVH, then its use can potentially have a major
impact on the neurological integrity and developmental outcome
of premature infants.
Figure 11. Noggin treatment enhances density of myelinated axons in pups with IVH at
ultrastructural level. A–C, Electron micrographs showing axons in the corona radiata of rabbit
pups without IVH (A), untreated pup with IVH (B), and noggin-treated pup with IVH (C). Note
myelinated (arrowheads) and unmyelinated (arrows) axons in the images. D, The bar chart
shows mean and SEM. The myelinated axons (arrowheads) were fewer in pups with IVH com-
pared with controls without IVH; and noggin treatment increased the density of myelinated
axons in pups with IVH. Scale bar, 1 m. *p  0.05 for the comparison between pups with and
without IVH. #p  0.05 for the comparison between noggin-treated and untreated pups with IVH.
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